Two Rare Mutations in the COL1A2 Gene Associate with Low Bone Mineral Density and Fractures in Iceland

Journal of Bone and Mineral Research

Volumn 31, Issue 1, 2016, Pages 173-179

  Styrkarsdottir, Unnur ^a   Thorleifsson, Gudmar ^a   Eiriksdottir, Berglind ^b   Gudjonsson, Sigurjon A ^a   Ingvarsson, Thorvaldur ^c,d   Center, Jacqueline R ^e,f,g   Nguyen, Tuan V ^e,g   Eisman, John A ^e,f,g,h   Christiansen, Claus ⁱ   Thorsteinsdottir, Unnur ^a,d   Sigurdsson, Gunnar ^d,j   Stefansson, Kari ^a,d  

^a DECODE GENETICS   (Iceland)

^b Genetic Research Service Center   (Iceland)

^c Akureyri Hospital   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h UNIVERSITY OF NOTRE DAME   (Australia)

ⁱ NORDIC BIOSCIENCE A S   (Denmark)

^j LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

more..

Author keywords

COLLAGEN; GENETIC RESEARCH; HUMAN ASSOCIATION STUDIES; STATISTICAL METHODS

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 2; UNCLASSIFIED DRUG; COL1A2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMALE; FOREARM FRACTURE; FRACTURE; FRAGILITY FRACTURE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIP; HIP FRACTURE; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MISSENSE MUTATION; OSTEOPOROSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPINE; SPINE FRACTURE; CLINICAL TRIAL; FRACTURES, BONE; GENETICS; INDEL MUTATION; MALE; MIDDLE AGED; MULTICENTER STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY; COLLAGEN TYPE I; FEMALE; FRACTURES, BONE; HUMANS; ICELAND; INDEL MUTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84957438660     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2604     Document Type: Article

References (48)

1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A., Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007; 22 (3): 465-75.
2. Johnell O, Kanis JA, Oden A, et al., Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20 (7): 1185-94.
3. Kanis J, Oden A, Johnell O, et al., The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporosis Int. 2007; 18 (8): 1033.
4. Ferrari S., Human genetics of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008; 22 (5): 723-35.
5. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al., Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008; 358 (22): 2355-65.
6. Richards JB, Rivadeneira F, Inouye M, et al., Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet. 2008; 371 (9623): 1505-12.
7. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al., New sequence variants associated with bone mineral density. Nat Genet. 2009; 41 (1): 15-7.
8. Xiong D-H, Liu X-G, Guo Y-F, et al., Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet. 2009; 84 (3): 388-98.
9. Rivadeneira F, Styrkarsdottir U, Estrada K, et al., Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009; 41 (11): 1199-206.
10. Kung AW, Xiao SM, Cherny S, et al., Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am J Hum Genet. 2010; 86 (2): 229-39.
11. Hsu Y-H, Zillikens MC, Wilson SG, et al., An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility loci for osteoporosis-related traits. PLoS Genet. 2010; 6 (6): e1000977.
12. Duncan EL, Danoy P, Kemp JP, et al., Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet. 2011; 7 (4): e1001372.
13. Estrada K, Styrkarsdottir U, Evangelou E, et al., Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012; 44 (5): 491-501.
14. Styrkarsdottir U, Thorleifsson G, Sulem P, et al., Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature. 2013; 497 (7450): 517-20.
15. Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tanko LB., Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int. 2007; 18 (4): 505-12.
16. Nguyen TV, Sambrook PN, Eisman JA., Sources of variability in bone mineral density measurements: implications for study design and analyses of bone loss. J Bone Miner Res. 1997; 12 (1): 124-35.
17. Gudbjartsson DF, Helgason H, Gudjonsson SA, et al., Large-scale whole-genome sequencing of the Icelandic population. Nat Genet. 2015; 47 (5): 435-44.
18. McKenna A, Hanna M, Banks E, et al., The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20 (9): 1297-303.
19. Kong A, Masson G, Frigge ML, et al., Detection of sharing by descent, long-range phasing and haplotype imputation. Nat Genet. 2008; 40 (9): 1068.
20. Kong A, Steinthorsdottir V, Masson G, et al., Parental origin of sequence variants associated with complex diseases. Nature. 2009; 462 (7275): 868-74.
21. Devlin B, Roeder K., Genomic control for association studies. Biometrics. 1999; 55 (4): 997-1004.
22. Holm S., A simple sequentially rejective multiple test procedure. Scand J Stat. 1979; 6: 65-70.
23. Helgason H, Rafnar T, Olafsdottir HS, et al., Loss-of-function variants in ATM confer risk of gastric cancer. Nat Genet. 2015; 47 (8): 906-10.
24. Kutyavin IV, Milesi D, Belousov Y, et al., A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res. 2006; 34 (19): e128.
25. Liu X, Jian X, Boerwinkle E., dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Hum Mutat. 2011; 32 (8): 894-9.
26. Liu X, Jian X, Boerwinkle E., dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat. 2013; 34 (9): E2393-E402.
27. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N,. A reference standard for the description of osteoporosis. Bone. 2008; 42 (3): 467-75.
28. Sillence D, Rimoin D., Classification of osteogenesis imperfecta. Lancet. 1978; 311 (8072): 1041-2.
29. Forlino A, Cabral WA, Barnes AM, Marini JC., New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011; 7 (9): 540-57.
30. Valadares ER, Carneiro TB, Santos PM, Oliveira AC, Zabel B., What is new in genetics and osteogenesis imperfecta classification? J Pediatr. 2014; 90 (6): 536-41.
31. Dalgleish R., The human type I collagen mutation database. Nucleic Acids Res. 1997; 25 (1): 181-7.
32. Dalgleish R., The human collagen mutation database 1998. Nucleic Acids Res. 1998; 26 (1): 253-5.
33. Sherry ST, Ward M-H, Kholodov M, et al., dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001; 29 (1): 308-11.
34. NHLBI Exome Sequencing Project (ESP), Exome Variant Server [Internet]. Seattle, WA: NHLBI ESP; v0017; 2012 Nov. Available from: http://evs.gs.washington.edu/EVS/.
35. Exome Aggregation Consortium (ExAC) [Internet]. Cambridge, MA: ExAC; 2014 Dec. Available from: http://exac.broadinstitute.org.
36. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH., Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet. 1996; 14 (2): 203-5.
37. Ralston SH, Uitterlinden AG, Brandi ML, et al., Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS Study. PLoS Med. 2006; 3 (4): e90.
38. Jin H, Evangelou E, Ioannidis JPA, Ralston SH., Polymorphisms in the 5′ flank of COL1A1 gene and osteoporosis: meta-analysis of published studies. Osteoporos Int. 2011; 22 (3): 911-21.
39. Symoens S, Hulmes DJ, Bourhis JM, Coucke PJ, Paepe AD, Malfait F., Type I procollagen C-propeptide defects: study of genotype-phenotype correlation and predictive role of crystal structure. Hum Mutat. 2014; 35 (11): 1330-41.
40. Einarsdottir SO., Osteogenesis imperfecta in Iceland. Reykjavik, Iceland: University of Iceland; 2006.
41. Ben Amor IM, Glorieux FH, Rauch F,. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos. 2011; 2011: 9.
42. Spotila LD, Constantinou CD, Sereda L, Ganguly A, Riggs BL, Prockop DJ., Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. Proc Natl Acad Sci. 1991; 88 (12): 5423-7.
43. Dawson PA, Kelly TE, Marini JC., Extension of phenotype associated with structural mutations in type I collagen: siblings with juvenile osteoporosis have an α2(I)Gly436 → Arg substitution. J Bone Miner Res. 1999; 14 (3): 449-55.
44. Lappalainen T, Montgomery Stephen B, Nica Alexandra C, Dermitzakis Emmanouil T., Epistatic selection between coding and regulatory variation in human evolution and disease. Am J Hum Genet. 2011; 89 (3): 459-63.
45. Keupp K, Beleggia F, Kayserili H, et al., Mutations in WNT1 cause different forms of bone fragility. Am J Hum Genet. 2013; 92 (4): 565-74.
46. Laine CM, Joeng KS, Campeau PM, et al., WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N Engl J Med. 2013; 368 (19): 1809-16.
47. Palomo T, Al-Jallad H, Moffatt P, et al., Skeletal characteristics associated with homozygous and heterozygous WNT1 mutations. Bone. 2014; 67 (0): 63-70.
48. Gong Y, Slee RB, Fukai N, et al., LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001; 107 (4): 513-23.